The purpose of the Drugs Patient Level Contract Monitoring Data Set (DrPLCM) is to enable the interchange, in a uniform format, of monthly PATIENT level drug Contract Monitoring data between all purchasers and Health Care Providers. This will ensure that drug Contract Monitoring and reporting is consistent, comparable and fit for purpose across all commissioning Organisations.
The Drugs Patient Level Contract Monitoring Data Set is a PATIENT level report containing PATIENT identifiers relating to high cost (National Tariff-excluded) drugs. Its purpose is to substantiate and provide detail to the aggregate information contained within the Aggregate Contract Monitoring Data Set (ACM).
The scope of the Drugs Patient Level Contract Monitoring Data Set is all NHS-funded PRESCRIBED ITEMS not reimbursed through National Tariff Payment System, as defined by the NHS Improvement National Tariff Payment System High Cost Tariff Excluded Drugs list, provided to PATIENTS for all NHS commissioners.
Note that the totality of expenditure in the Drugs Patient Level Contract Monitoring Data Set must be equivalent to the aggregate monetary value shown relating to High Cost Tariff Excluded Drugs in the Aggregate Contract Monitoring Data Set.
The Drugs Patient Level Contract Monitoring Data Set is required to be submitted on a monthly basis to the respective Data Services for Commissioners Regional Office (DSCRO) as nominated by each commissioning function in line with the dates documented in the data submission timetable within Schedule 6 of the NHS Standard Contract.
For further information on the Drugs Patient Level Contract Monitoring Data Set, see the NHS England website at: Directly Commissioned Services Reporting Requirements.